CLINICAL TRIALS PROFILE FOR MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)
✉ Email this page to a colleague
All Clinical Trials for MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00534378 ↗ | Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector | Completed | U.S. Army Office of the Surgeon General | Phase 1 | 2006-07-01 | Purpose of the study is to determine midazolam's safety and dose-linearity when delivered intramuscularly via an autoinjector. The proposed initial treatment dosage for seizures induced by exposure to nerve agents. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)
Condition Name
Clinical Trial Locations for MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)
Trials by Country
Clinical Trial Progress for MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)
Clinical Trial Phase
Clinical Trial Sponsors for MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)
Sponsor Name